Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Arzoxifene on Bone Mineral Density and Endometrial Histology in Postmenopausal Women.

NCT00085956 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00085956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00085956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Arzoxifene on Bone Mineral Density and Endometrial Histology in Postmenopausal Women.
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
February 28, 2007
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal bone loss